Semaglutide improves health-related quality of life versus placebo when added to standard of care in patients with type 2 diabetes at high cardiovascular risk (SUSTAIN 6)

E Jódar, M Michelsen, W H Polonsky, R Réa, A Sandberg, T Vilsbøll, M Warren, S Harring, U Ziegler, S C Bain

17 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Semaglutide improves health-related quality of life versus placebo when added to standard of care in patients with type 2 diabetes at high cardiovascular risk (SUSTAIN 6)'. Together they form a unique fingerprint.

Medicine & Life Sciences